Qiang Wang

Qiang Wang

Auto-generated profile, based on publicly available information

Qiang Wang

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
JMJingyuan Mao
Jingyuan Mao
YGYong-Bin Ge
Yong-Bin Ge
HWHeng-He Wang
Heng-He Wang
QWQiang Wang
Qiang Wang
YZyun zhang
yun zhang
CZChunyan Zhao
Chunyan Zhao

16 June 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SLShichao Lv
Shichao Lv
QWQiang Wang
Qiang Wang
MWMeifang Wu
Meifang Wu
MLMeng Li
Meng Li
XWXiaojing Wang
Xiaojing Wang
JZJunping Zhang
Junping Zhang
Pressure-overloaded myocardial hypertrophy is an independent risk factor for various cardiovascular diseases (CVDs), such as heart failure (HF), arrhythmia, and even sudden death. It is reported that QiShenYiQi pill (QSYQ) is widely used in the treatment of CVDs and can prevent pathological hypertrophy of myocardium, but its specific mechanism is still unclear. In this study, a rat model of myocardial hypertrophy was established through the pressure overload caused by abdominal aortic constriction in Wistar rats. The rats were randomly divided into model group, valsartan group, and QSYQ group, and sham-operated animals served as the control group. At the 4 and 8 weeks of intervention, the general morphology of the heart, myocardial collagen content, collagen volume factor (CVF), collagen type I, collagen type III, myocardial pathological changes, and the expression of ANP, β-MHC, TGF-β1, and CTGF were analyzed, respectively, in order to explore the possible effect of QSYQ on the mechanism of myocardial hypertrophy. We observed that QSYQ could effectively improve myocardial hypertrophy in pressure-overloaded rats, which was related to the regulatory mechanism of TGF-β1 and CTGF.